Systemic B-cell abnormalities in patients with atopic dermatitis? - 01/07/16
Doi : 10.1016/j.jaci.2016.01.038
Jorn J. Heeringa, MD a, Enes Hajdarbegovic, MD b, H. Bing Thio, MD, PhD b, Menno C. van Zelm, PhD a, c 
a Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
b Department of Dermatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
c Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Le texte complet de cet article est disponible en PDF.
| The study was supported by the Sophia Children's Hospital Fund (grant no. S698). |
|
| Disclosure of potential conflict of interest: J. J. Heeringa has received a grant from Sophia Children's Hospital Fund. M. C. van Zelm has received a grant from Sophia Children's Hospital Fund and has a patent for IgE-expressing B cells (PCT-NL2001-050781). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 1
P. 317-318 - juillet 2016 Retour au numéro
Article précédent
- Reply
- Danilo Di Bona, Antonella Plaia, Gabriele Di Lorenzo
- Reply
- Tali Czarnowicki, James G. Krueger, Emma Guttman-Yassky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?